Endocrine Disruptors, The European Green Deal And The Politicization Of EU Chemical Programs
Executive Summary
John Chave, director-general at Cosmetics Europe, says the European Commission’s plan for targeted assessment of 28 potential endocrine-disruptors in cosmetics – despite its conclusion in late 2018 that the current cosmetics regulatory framework adequately addresses endocrine-disruptor concerns – is symptomatic of a broad trend taking hold in Europe.
You may also be interested in...
European SEAC Opinion Unchanged: Microplastics Must Be Out Of All Cosmetics Within Six Years
The final opinion of ECHA’s Socio-Economic Analysis Committee, published on 1 March, is largely unchanged from its July 2020 draft opinion with regard to microplastic in cosmetic products. That means industry may have to convince EU member state authorities that the restriction proposal has a serious proportionality problem.
EU Chemicals Strategy Stands To Transform Cosmetics Regulation
Cosmetics Europe Director-General John Chave says whichever way the European Commission proceeds under its recently released sustainable chemicals strategy, there almost certainly will need to be changes to the Cosmetic Products Regulation. Chave counts the strategy among “the biggest legislative policy proposals affecting our sector probably ever.”
Cruelty Free Europe Grieves: ‘Very Little Left Now’ Of Cosmetic Animal-Testing Bans
The European Chemicals Agency's Board of Appeal finds that REACH requires ingredient registrants to perform animal studies, even if their substances are used exclusively in cosmetic products. Historically opposed industry and animal welfare groups both may lose under the board’s decisions.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: